4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014624
Director sold 12,452 shares at $10.24 ($127,477)
- Director acquired 21,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kauffman Michael Director | 2022-02-28 | Grant or award | +21,000 | 719,983 | D: show line 1 in the form | ||
| Kauffman Michael Director | 2022-02-28 | Sale | −6,226 | $10.24 | $63,739 | 713,757 | D: show line 2 in the form |
| Kauffman Michael Director | 2022-02-28 | Sale | −6,226 | $10.24 | $63,739 | 898,131 | I: show line 3 in the form |
| Open-market sales · 12,452 sh · avg $10.24 · $127,477 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kauffman Michael Director | 2022-02-28 | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…